Managing Afternoon ADHD Symptoms in Children on Monotherapy

Introduction to ADHD Management

The American Academy of Child and Adolescent Psychiatry recommends adding a low-dose immediate-release stimulant, such as methylphenidate 5mg or mixed amphetamine salts 2.5mg, in the early afternoon to address breakthrough symptoms in children on guanfacine monotherapy, as guanfacine alone may provide insufficient daytime coverage 1

Guanfacine provides "around-the-clock" effects without wearing off, but has smaller effect sizes than stimulants and takes 2-12 weeks to reach full efficacy, meaning children have likely reached maximum benefit from the current dose 1
Stimulants demonstrate 70-80% response rates with effect sizes around 1.0, making them the gold standard first-line treatment for ADHD 2

The Journal of the American Academy of Child and Adolescent Psychiatry suggests starting with methylphenidate 5mg given after breakfast, or mixed amphetamine salts 2.5mg in the early morning, with the stimulant taking effect within 30 minutes and providing 4-6 hours of coverage during school hours 3, 1
The dose can be increased weekly by 5mg increments for methylphenidate (or 2.5mg for amphetamines) until symptoms improve or side effects emerge, with total daily methylphenidate doses ranging from 10-60mg as needed 3, 4

The American Academy of Child and Adolescent Psychiatry recommends checking blood pressure and pulse at baseline and with each dose adjustment, as both guanfacine and stimulants can affect these parameters 1
Monitoring for decreased appetite, insomnia, and irritability from the stimulant, as well as guanfacine's common effects, is crucial, with weighing the child at each visit to detect potential weight loss from appetite suppression 3, 5, 4

Avoid administering afternoon stimulant doses after 3-4 PM to prevent sleep disturbances, and consider the timing of a third stimulant dose for homework to minimize sleep impact 1, 2, 3

Atomoxetine could be considered as an alternative non-stimulant, but it takes 2-12 weeks to reach efficacy and has lower effect sizes than stimulants, according to the American Academy of Child and Adolescent Psychiatry 1

The American Academy of Child and Adolescent Psychiatry advises against assuming the current regimen just needs more time, and against increasing guanfacine above 3mg/day, as adverse effects increase significantly while therapeutic benefit plateaus 2
Stimulants should typically be first-line unless contraindicated, and dosing stimulant boosters too late in the day significantly increases insomnia risk, according to the American Academy of Child and Adolescent Psychiatry 2